The Latest in Diabetes

Closed-loop delivery system increases time in target glucose range

October 18, 2019

Diabetes

Clinical Pharmacists Improve Patient Outcomes and Expand Access to Care

October 3, 2019

Diabetes

Liraglutide ‘option’ for treating pediatric type 2 diabetes

October 2, 2019

Diabetes

Smoking, inactivity most powerful post-MI lifestyle risk factors

October 1, 2019

Diabetes

Panel releases guidelines for red meat, processed meat consumption

September 30, 2019

Diabetes

FDA adds diabetic kidney disease, heart failure indications to canagliflozin

September 30, 2019

Diabetes

COMISAIR: CGM ‘makes the difference’ in type 1 diabetes

September 26, 2019

Diabetes

RISE analyses highlight further youth vs. adult T2D differences

September 25, 2019

Diabetes

CONCLUDE data inconclusive on hypoglycemia risk for degludec vs. glargine

September 24, 2019

Diabetes

Machine learning–derived risk score predicts heart failure risk in diabetes patients

September 22, 2019

Diabetes

Semaglutide beats canagliflozin as second-line therapy for type 2 diabetes

September 20, 2019

Diabetes

FDA approves oral semaglutide for HbA1c management in type 2 diabetes

September 20, 2019

Diabetes

First data VERIFY value of early combination therapy in type 2 diabetes

September 19, 2019

Diabetes

Dapagliflozin given Fast Track status for HF therapy

September 16, 2019

Diabetes

NICE issues recommendation for dapagliflozin-insulin therapy in type 1 diabetes

September 6, 2019

Diabetes